摘要:
The invention encompasses the novel compound of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.
摘要:
The invention relates to methods and systems for receiving, processing and fulfilling remotely placed orders. In one aspect, requests to place an order are received from a remote location, and based on a customer identifier included in the request, customer preference data is retrieved. An electronic selection menu based on customer preference data is transmitted to the customer, the order is received and prepared. The customer's arrival is automatically detected, and the completed order is provided to the customer.
摘要:
The present invention relates to biaryl piperidine-based renin inhibitor compounds, and their use in treating cardiovascular events and renal insufficiency.
摘要:
The invention relates to methods and systems for receiving, processing and fulfilling remotely placed orders. In one aspect, requests to place an order are received from a remote location, and based on a customer identifier included in the request, customer preference data is retrieved. An electronic selection menu based on customer preference data is transmitted to the customer, the order is received and prepared. The customer's arrival is automatically detected, and the completed order is provided to the customer.
摘要:
This invention describes a reductive amination process whereby perfluorinated ketones or ketals are combined with α-aminoesters under basic conditions to form metal carboxylates. Diastereoselective reductions of the metal carboxylates enable access to two diastereomers, depending on the reducing conditions.
摘要:
The invention encompasses the novel compound of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.
摘要:
The invention encompasses the novel compound of Formula I as well as a method of treating COX-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of Formula I. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of COX-2 mediated diseases comprising compounds of Formula I.
摘要:
This invention describes a reductive amination process whereby perfluorinated ketones or ketals are combined with α-aminoesters under basic conditions to form metal carboxylates. Diastereoselective reductions of the metal carboxylates enable access to two diastereomers, depending on the reducing conditions.